Little Green Pharma (LGP) has won a government tender to be a primary supplier of medicinal cannabis oils for a national trial in France
The two-year trial will test the efficacy, safety and quality of medicinal cannabis products in up to 3000 patients
As part of the trial, LGP will partner with leading pharmaceutical distributor, Intsel Chimos, who will undertake batch-release, distribution, medical information and drug safety obligations
Little Green Pharma will be responsible for manufacturing and supplying its medicines into France at its own costUltimately, if the trial is successful, it may lead to the legalisation of medicinal cannabis in France — providing LGP with a "first-mover advantage"
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)